Anaplastic Large Cell Lymphoma (ALCL) is a rare type of non-Hodgkin lymphoma that affects the lymphatic system. It is characterized by the presence of large, abnormal cells in the lymph nodes, which can cause swelling and pain in the affected areas. ALCL can be further classified into different subtypes based on the presence or absence of a protein called anaplastic lymphoma kinase (ALK) in the cancer cells.
ALK-negative ALCL is a subtype of the condition that does not have the ALK protein. It accounts for about 30% of all cases of ALCL and is more common in adults than in children. It typically affects the lymph nodes of the axilla (armpit) and upper limb, although it can also occur in other parts of the body.
ALCL is thought to develop when certain white blood cells called T-cells become abnormal and start to grow and divide uncontrollably. The exact cause of this transformation is not known, but it may be linked to genetic mutations or exposure to certain chemicals or viruses.
The symptoms of ALCL can vary depending on the location and extent of the cancer. In ALK-negative ALCL, the most common symptoms include:
Diagnosis of ALCL typically involves a combination of imaging tests, such as CT scans and PET scans, and biopsy of the affected lymph nodes or other tissues. Further testing may be done to determine the subtype of ALCL and to assess the extent of the cancer.
While the exact cause of ALCL is not known, there are several treatment options available for the condition. These may include chemotherapy, radiation therapy, and stem cell transplantation. The choice of treatment will depend on the subtype of ALCL, the extent of the cancer, and other factors such as the age and overall health of the patient.
If you are experiencing symptoms of ALCL, it is important to see your doctor for an evaluation. Early diagnosis and treatment can improve outcomes and reduce the risk of complications.
To see full information about treatment please Sign up or Log in